High Content Screening Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Global High Content 
Screening Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  la tes t  repor t  by  IMARC Group ,  t i t led  "High Content  
Screening Market :  G loba l  Indus try  Trends ,  Share ,  S ize ,  Growth,  
Oppor tuni ty  and  Forecas t  2024 -2032 ,"  the  g loba l  h igh  con ten t  sc reen ing  
marke t  s ize  reached  US$  1 .3  B i l l ion  in  2023 .
Report High  con ten t  sc reen ing  (HCS)  re fe rs  to  an  advanced  approach  o f  ce l l -based  
sc reen ing  in  d rug  d iscove ry  and  sys tems b io logy  tha t  u t i l i zes  v isua l i za t ion  
Highlight and too ls  to  ga the r  quan t i ta t i ve  da ta  f rom ce l l  popu la t ions .  I t  invo lves  the  usage  o f  
quan t i ta t i ve  da ta  ana lys i s  and  au tomated  imag ing  in  a  h igh - th roughpu t  fo rmat .  
A lso  known as  h igh  con ten t  ana lys is ,  i t  emp loys  mu l t i co lo r  f luo rescence  
Description imag ing  to  ana lyze  severa l  b iochemica l  and  phys ica l  charac te r is t i cs  o f  t he  
samp le  ce l l s .  As  a  resu l t ,  t h is  ana ly t i ca l  method  o f  au tomated  mic roscopy  
ass is t s  in  comp lex  mu l t i va r ia te  d rug  p ro f i l ing  and  tox ic i t y  s tud ies .
Request  for  a  PDF sample  of  th is  report :  
h t tps : / /www. imarcgroup .com/h igh-con ten t -sc reen ing -marke t / reques tsamp le
Report Description
G l ob a l  H i gh  Cont en t  Sc reen i ng  M ark e t  T rend s :
The  g loba l  m ar k e t  i s  m a j o r l y  d r i ven  by  t he  i nc r eas in g  i nc ide nces  o f  ch r on i c  ne u r od egen e r a t i v e  d i sea ses ,  such  as  
Pa r k i nson ’ s  a nd  A l zhe im er ’s .  T h i s  has  l ed  t o  t he  g r ow ing  need  f o r  a f f o r d ab le  and  e f f e c t i ve  d r u g  d i sc ove r y  sy s t em s  on  t h e  
g loba l  l e ve l ,  wh i c h  i s  p r ov id in g  an  im pe t us  t o  t he  m ar ke t  g r ow t h .  H CS i s  w id e l y  p r e f e r r ed  by  p r o f e ss ion a l s  as  t h i s  m e t h od  
o f  m ic r oscop y  a ids  i n  an a l yz in g  t he  po t e n t i a l  t ox ic i t y  o f  chem ica l s  an d  co m p le x  su bs t a nces  i n  a  r esou r c e - e f f i c i en t  
m an ne r .  The  m ar k e t  i s  f u r t h e r  d r i ven  by  con t i n ua l  d eve lop m en t s  i n  i n f o r m a t i cs  so lu t i on s  an d  im a g ing  in s t r u m en t s .  
M or e ove r ,  n um e r ous  key  p lay e r s  a r e  a l so  i n t r odu c ing  i nno va t i ve  HCS  e qu ipm en t  i n  t he  m ar ke t  t ha t  a r e  e qu ipp ed  w i t h  
so f t wa r e  p la t f o r m s  a nd  a r t i f i c i a l  i n t e l l i gence  ( A I )  sys t em s  i n  an  a t t em p t  t o  im p r ove  t he  v i sua l i za t i on  c apab i l i t i es  o f  t h e  
sys t e m s .  S om e o f  t he  o t he r  f a c t o r s  c on t r i b u t i ng  t o  t h e  m ar ke t  g r ow t h  i nc l ude  t he  g r o w ing  ge r i a t r i c  pop u la t i on ,  t he  adven t  
o f  au t om a t ed  sys t em s  f o r  an a l yz ing  c e l l  sep a r a t i on  and  sc a lab i l i t y ,  and  ex t ens i ve  r es ea r c h  a nd  deve lopm en t  ( R&D )  
ac t i v i t i es  c ondu c t ed  by  m a jo r  p laye r s .
Look i ng  f o rw ard ,  t he  mark e t  i s  an t i c i p a t ed  t o  g r ow  a t  a  CAG R o f  7 . 5%  dur i ng  2024 - 2032 .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / h i gh- c ont en t - sc reen i ng- m ark e t
Breakup by Product:
• Instruments
o Cel l  Imaging and Analysis Systems
o Flow Cytometers
• Consumables
o Reagents & Assay Kits
o Microplates
Report o Others
Segmentation • Software
• Services
• Accessories
 
Breakup by Application:
• Target Identifi cat ion and Val idat ion
• Primary Screening and Secondary Screening
• Toxicity Studies
• Compound Profi l ing
• Others
Breakup by End-User:
• Pharmaceutical  and Biotechnology Companies
• Academic and Government Insti tutes
Report • Contract Research Organizations (CROs)
Segmentation
Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Becton
• Dickinson and Company
• Bio-Rad Laboratories Inc.
Competitive • Biotek Instruments Inc.
• Danaher Corporation
Landscape 
• GE Healthcare
with Key • Merck Mi l l ipore
Players • Perkinelmer Inc.
• Tecan Group Ltd.
• Thermo Fisher Scient ifi c
• Yokogawa Electric Corporation.
How has the global high content screening market 
performed so far, and how will it perform in the coming 
years?
What are the drivers, restraints, and opportunities in 
the global high content screening market?
What is the impact of each driver, restraint, and 
Key opportunity on the global high content screening market?
Questions What are the key regional markets?
Answered in 
Which countries represent the most attractive high 
the Report content screening market?
What is the breakup of the market based on the 
product?
Which is the most attractive product in the high content 
screening market?
What is the breakup of the market based on the 
application?
Which is the most attractive application in the high 
content screening market?
What is the breakup of the market based on the end-
user?
Key 
Which is the most attractive end-user in the high 
content screening market?
Questions 
Answered in What is the competitive structure of the market?
the Report
Who are the key players/companies in the global high 
content screening market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  H i g h  C o n t e n t  S c r e e n i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t  
    6 . 1     I n s t r u m e n t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a j o r  T y p e s
             6 . 1 . 2 . 1  C e l l  I m a g i n g  a n d  A n a l y s i s  S y s t e m s
             6 . 1 . 2 . 2  F l o w  C y t o m e t e r s
        6 . 1 . 3  M a r k e t  F o r e c a s t
    6 . 2     C o n s u m a b l e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a j o r  T y p e s
       
             6 . 2 . 2 . 1  R e a g e n t s  &  A s s a y  K i t s
             6 . 2 . 2 . 2  M i c r o p l a t e s
             6 . 2 . 2 . 3  O t h e r s
        6 . 2 . 3  M a r k e t  F o r e c a s t
    6 . 3     S o f t w a r e
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
    6 . 4     S e r v i c e s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     A c c e s s o r i e s
Table of         6 . 5 . 1  M a r k e t  T r e n d s        6 . 5 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    7 . 1     T a r g e t  I d e n t i f i c a t i o n  a n d  V a l i d a t i o n
Contents         7 . 1 . 1  M a r k e t  T r e n d s        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     P r i m a r y  S c r e e n i n g  a n d  S e c o n d a r y  S c r e e n i n g
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
    7 . 3     T o x i c i t y  S t u d i e s
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
    7 . 4     C o m p o u n d  P r o f i l i n g
        7 . 4 . 1  M a r k e t  T r e n d s
        7 . 4 . 2  M a r k e t  F o r e c a s t   
    7 . 5     O t h e r s
        7 . 5 . 1  M a r k e t  T r e n d s
        7 . 5 . 2  M a r k e t  F o r e c a s t   
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /h i gh - c o n ten t - sc reen i ng -m a rke t / t
o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: